Search Instructions:

* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Browse Items (211 total)

  • Subject is exactly "Treatment & Care"

LTC_Biosafety_Identify_Isolate_and_Infom_Final Reduced.pdf
Creator: NETEC
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-12-12
Description: This printable flyer discusses Long-Term Care (LTC) and Assisted Living Facility Biosafety: Identify, Isolate and Inform.

Creator: Koehler, Philipp, Matteo Bassetti, Arunaloke Chakrabarti, Sharon C. A. Chen, Arnaldo Lopes Colombo, Martin Hoenigl, Nikolay Klimko, Cornelia Lass-Flörl, Rita O. Oladele, Donald C. Vinh, Li-Ping Zhu, Boris Böll, Roger Brüggemann, Jean-Pierre…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-12-14
Description: Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary aspergillosis have raised concerns about it worsening the disease course of…

default_publication_icon.png
Creator: Kalil, A. C., T. F. Patterson, A. K. Mehta, K. M. Tomashek, C. R. Wolfe, V. Ghazaryan, V. C. Marconi, G. M. Ruiz-Palacios, L. Hsieh, S. Kline, V. Tapson, N. M. Iovine, M. K. Jain, D. A. Sweeney, H. M. El Sahly, A. R. Branche, J. Regalado Pineda, D.…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-12-11
Description: Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known.

Alternate Care Sites Final reduced.pdf
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-12-18
Description: In this webinar, we will identify efficient operational processes when coordinating alternative care sites for patients who are critically-ill related to COVID-19, describe how effective leadership strategies of the interdisciplinary team across care…

Creator: Prado-Vivar, Belén, Mónica Becerra-Wong, Juan José Guadalupe, Sully Márquez, Bernardo Gutierrez, Patricio Rojas-Silva, Michelle Grunauer, Gabriel Trueba, Verónica Barragán, and Paúl Cárdenas.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-23
Description: Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection have been reported in Hong Kong, Belgium, the Netherlands, and the USA.A response to this article was published:Pallett, Scott J. C., Rachael Jones, Paul Randell, Gary…

Creator: David C. Fajgenbaum, and Carl H. June.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-12-03
Description: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has reminded us of the critical role of an effective host immune response and the devastating effect of immune dysregulation. This year marks 10 years since the first…

casirivimab and imdevimab EUA fact sheet for healthcare providers_0.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…

default_website_icon.png
Creator: Infectious Diseases Society of America (IDSA)
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.

default_publication_icon.png
Creator: Manzano, Giovanna S., Jared K. Woods, and Anthony A. Amato.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…

Monoclonal Antibody Therapeutics Final.pdf
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…